Commonwealth Equity Services, LLC Tyme Technologies, Inc. Transaction History

Commonwealth Equity Services, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 04, 2021	SELL	$1.34 - $3.53 $17,688 - $46,596	-13,200 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$0.87 - $1.26 $11,484 - $16,632	13,200 New	13,200 $16,000

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.